Premature atherosclerosis in non-transfusion-dependent β-thalassemia intermedia

Cardiology

Volumn 118, Issue 3, 2011, Pages 159-163

  Hahalis, George ^a,d   Kalogeropoulos, Andreas ^a   Terzis, George ^a   Tselepis, Alexandros D ^b   Kourakli, Alexandra ^a   Mylona, Panagiota ^a   Grapsas, Nikos ^c   Alexopoulos, Dimitrios ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

^c UNIVERSITY GENERAL HOSPITAL OF PATRAS   (Greece)

^d NONE   (Greece)

Author keywords

Atherosclerosis; Coronary artery; Thalassemia intermedia

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; D DIMER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBRIN; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTERIAL WALL THICKNESS; ARTERY BLOOD FLOW; ARTERY DIAMETER; ARTERY DILATATION; ARTICLE; ATHEROSCLEROSIS; BETA THALASSEMIA; BRACHIAL ARTERY; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL;

EID: 79957863697     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000327997     Document Type: Article

References (16)

1. Taher A, Isma'eel H, Cappellini MD: Thalas-semia intermedia: revisited. Blood Cells Mol Dis 2006; 37: 12-20.
2. Taher A, Isma'eel H, Mehio G, et al: Pre-valence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran. Thromb Haemost 2006; 96: 488-491. (Pubitemid 44560684)
3. Fridlender ZG, Rund D: Myocardial infarc-tion in a patient with beta-thalassemia ma-jor: first report. Am J Hematol 2004; 75: 52-55. (Pubitemid 38040168)
4. Tassiopoulos S, Deftereos S, Konstantopou-los K, et al: Does heterozygous beta-thalasse-mia confer a protection against coronary ar-tery disease? Ann NY Acad Sci 2005; 1054: 467-470. (Pubitemid 43031058)
5. Kyriakou DS, Alexandrakis MG, Kyriakou ES, et al: Activated peripheral blood and en-dothelial cells in thalassemia patients. Ann Hematol 2001; 80:577-583. (Pubitemid 33061997)
6. Kanavaki I, Makrythanasis P, Lazaropoulou C, et al: Soluble endothelial adhesion mole-cules and inflammation markers in patients with beta-thalassemia intermedia. Blood Cells Mol Dis 2009;43:230-234.
7. Lorenz MW, Markus HS, Bots ML, Ros-vall M, Sitzer M: Prediction of clinical car-diovascular events with carotid intima-me-dia thickness: a systematic review and meta-analysis. Circulation 2007; 115:459-467. (Pubitemid 46184197)
8. Sorensen HT, Horvath-Puho E, Pedersen L, Baron JA, Prandoni P: Venous thromboem-bolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study. Lancet 2007; 370: 1773-1779. (Pubitemid 350137491)
9. Hahalis G, Kremastinos DT, Terzis G, et al: Global vasomotor dysfunction and acceler-ated vascular aging in beta-thalassemia ma-jor. Atherosclerosis 2008; 198: 448-457. (Pubitemid 351707383)
10. Hahalis G, Manolis AS, Gerasimidou I, Alexopoulos D, Sitafidis G, Kourakli A, Kör-fer R, Koerner MM, Vagenakis AG, Zoum-bos NC: Right ventricular diastolic func-tion in beta-thalassemia major: echocardio-graphic and clinical correlates. Am Heart J 2001; 141: 428-434. (Pubitemid 32200272)
11. Calandra S, Bertolini S, Pes GM, et al: Beta-thalassemia is a modifying factor of the clin-ical expression of familial hypercholesterol-emia. Semin Vasc Med 2004; 4:271-278. (Pubitemid 40094492)
12. Livrea MA, Tesoriere L, Maggio A, DArpa D, Pintaudi AM, Pedone E: Oxidative modi-fication of low-density lipoprotein and ath-erogenetic risk in beta-thalassemia. Blood 1998; 92:3936-3942. (Pubitemid 28525220)
13. Redgrave JN, Lovett JK, Gallagher PJ, Roth-well PM: Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symp-toms: the Oxford plaque study. Circulation 2006; 113: 2320-2328. (Pubitemid 43947978)
14. Virmani R, Ladich ER, Burke AP, Kolodgie FD: Histopathology of carotid atherosclerot-ic disease. Neurosurgery 2006; 59:S219-S227, discussion S3-S13.
15. Glynn RJ, Danielson E, Fonseca FA, et al: A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med 2009; 360: 1851-1861.
16. Mahmoodi BK, Gansevoort RT, Veeger NJ, et al: Microalbuminuria and risk of venous thromboembolism. JAMA 2009; 301: 1790-1797.